We are live on ! Find out more
BCM

BIOS Capital Management Portfolio holdings

AUM $52.9M
1-Year Est. Return 30.51%
This Fund
S&P 500
This Quarter Est. Return
-5.43%
1 Year Est. Return
+30.51%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$82.6M
AUM Growth
-$6.29M
Cap. Flow
-$86.3K
Cap. Flow %
-0.1%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
2
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
INAB icon
IN8bio
INAB
+$63.2K
2
LTRN icon
Lantern Pharma
LTRN
+$23.1K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACTU
1
Actuate Therapeutics
ACTU
$28.2M
$61.5M 74.44%
10,049,996
– –
CGTX icon
2
Cognition Therapeutics
CGTX
$82.3M
$8.1M 9.8%
6,000,000
– –
IRD
3
Opus Genetics
IRD
$254M
$7.4M 8.96%
3,683,429
– –
LTRN icon
4
Lantern Pharma
LTRN
$35.1M
$3.06M 3.7%
1,009,507
-6,208
-0.6% -$23.1K
RNTX
5
Rein Therapeutics
RNTX
$67.7M
$1.96M 2.37%
1,690,751
– –
INAB icon
6
IN8bio
INAB
$11.5M
$593K 0.72%
253,417
-33,247
-12% -$63.2K

Similar funds

FRGX
First Reserve GP XIII Stamford, Connecticut $52.9M AUM 17.37% 1-Year Est. Return
ICM
Irth Capital Management New York $52.8M AUM 21.11% 1-Year Est. Return
SCP
SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM
GMEI
Global Media & Entertainment Investments Nassau, Bahamas $53M AUM 0% 1-Year Est. Return
TP
Toronado Partners San Francisco, California $53M AUM 13.38% 1-Year Est. Return
ETCM
Evolutionary Tree Capital Management Alexandria, Virginia $53.2M AUM 13.56% 1-Year Est. Return
WEO
William E. Oberndorf $53.3M AUM 10.89% 1-Year Est. Return
NCM
Notable Capital Management Menlo Park, California $53.4M AUM 10.98% 1-Year Est. Return

BIOS Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, BIOS Capital Management held 6 positions worth $82.6M, down 7.1% from $88.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2025: portfolio turnover was 0%. BIOS Capital Management opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • BIOS Capital Management's biggest Q4 2025 reduction was IN8bio, cutting an estimated $63.2K.
  • BIOS Capital Management's ten largest holdings make up 100% of its $82.6M portfolio in Q4 2025.
  • BIOS Capital Management opened 0 new positions and closed 0 in Q4 2025.
  • BIOS Capital Management's portfolio value fell 7.1% quarter-over-quarter to $82.6M.

Based on BIOS Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.